Literature DB >> 25422327

Takayasu's arteritis occurring under TNF-α blockers: a new paradoxical effect?

Leila Souabni1, Kaouther Ben Abdelghani1, Saoussen Jradi1, Leith Zakraoui1.   

Abstract

Takayasu's arteritis (TA) is a rare granulomatous vasculitic disease. Recently, experimental studies and several case reports have supported the use of anti-tumour necrosis factor (TNF) therapy for severe forms of TA. We report a case of a 58-year-old woman who was followed for spondyloarthritis. Her disease was resistant to non-steroidal anti-inflammatory drugs, and TNF-α blockers were initiated. The patient developed asthaenia and severe back pain. The erythrocyte sedimentation rate was 82 mm and C reactive protein was 192 mg/L. Based on thickened walls of large vessel on MRI, a diagnosis of TA was established. Under corticosteroids and after discontinuation of TNF-α blockers, the patient remained free of symptoms at 8-month follow-up. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25422327      PMCID: PMC4244516          DOI: 10.1136/bcr-2014-204226

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Giant cell arteritis in a patient taking etanercept and methotrexate.

Authors:  Margaret Seton
Journal:  J Rheumatol       Date:  2004-07       Impact factor: 4.666

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  Takayasu's arteritis progression on anti-TNF biologics: a case series.

Authors:  Mohammed Osman; Stephen Aaron; Michelle Noga; Elaine Yacyshyn
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

Review 4.  Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.

Authors:  Cloé Comarmond; Emmanuel Plaisier; Karine Dahan; Tristan Mirault; Joseph Emmerich; Zahir Amoura; Patrice Cacoub; David Saadoun
Journal:  Autoimmun Rev       Date:  2011-12-04       Impact factor: 9.754

5.  How should we diagnose spondyloarthritis according to the ASAS classification criteria: a guide for practicing physicians.

Authors:  Rosaline van den Berg; Désirée M F M van der Heijde
Journal:  Pol Arch Med Wewn       Date:  2010-11

6.  Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France.

Authors:  Bernadette Saint Marcoux; Michel De Bandt
Journal:  Joint Bone Spine       Date:  2006-08-30       Impact factor: 4.929

Review 7.  Autoimmune diseases induced by biological agents: a double-edged sword?

Authors:  Manuel Ramos-Casals; Candido Diaz-Lagares; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Autoimmun Rev       Date:  2009-10-23       Impact factor: 9.754

Review 8.  Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy.

Authors:  Nagaaki Katoh; Mayu Kubota; Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Taiji Akamatsu; Shu-ichi Ikeda
Journal:  Intern Med       Date:  2010-01-15       Impact factor: 1.271

9.  Refractory Takayasu arteritis successfully treated with infliximab.

Authors:  S Maffei; M Di Renzo; S Santoro; L Puccetti; A L Pasqui
Journal:  Eur Rev Med Pharmacol Sci       Date:  2009 Jan-Feb       Impact factor: 3.507

Review 10.  Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies.

Authors:  Alison Clifford; Gary S Hoffman
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

View more
  3 in total

1.  Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis.

Authors:  Nuh Ataş; Özkan Varan; Hakan Babaoğlu; Hasan Satiş; Reyhan Bilici Salman; Abdurrahman Tufan
Journal:  Arch Rheumatol       Date:  2019-03-28       Impact factor: 1.472

Review 2.  Takayasu's arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?

Authors:  Amel Rezgui; Maissa Thabet; Sahar Makki; Jihed Anoun; Imen Ben Hassine; Monia Karmeni; Fatma Ben Fredj; Anis Mzabi; Chedia Laouani
Journal:  Reumatologia       Date:  2021-02-09

3.  Infliximab-Induced Granulomatous Vasculitis With Amyloid Deposition in the Tongue of a Patient With Behçet Disease.

Authors:  Sari Iwasaki; Toshiyuki Watanabe; Takahiro Tsuji; Takuya Otsuka; Keishi Makita; Yuichiro Fukasawa; Akihiro Ishizu
Journal:  J Clin Rheumatol       Date:  2021-12-01       Impact factor: 3.902

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.